share_log

BRIEF-Trillium Therapeutics Inc Says Pfizer Voluntarily Withdrew Its Hart-Scott-Rodino Act Filing, And Expects To Re-File Such Form On Or About October 14

reuters ·  2021/10/13 09:52

Oct 13 (Reuters) - Trillium Therapeutics Inc TRIL.TO :

* TRILLIUM THERAPEUTICS - ON OCT 12, 2021, PFIZER VOLUNTARILY WITHDREW ITS HART-SCOTT-RODINO ACT FILING, AND EXPECTS TO RE-FILE SUCH FORM ON OR ABOUT OCTOBER 14

* TRILLIUM THERAPEUTICS INC - CO, PFIZER ARE WORKING COOPERATIVELY WITH APPLICABLE REGULATORY AUTHORITIES IN THEIR REVIEW OF PROPOSED ARRANGEMENT

* TRILLIUM THERAPEUTICS INC - CO, PFIZER CONTINUE TO EXPECT TO CONSUMMATE ARRANGEMENT IN Q4 OF 2021 OR FIRST HALF OF 2022

Further company coverage: TRIL.TO

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする